A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families-Reference-Cited by-同舟云学术

A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families

Published:2017-06-01 Issue:4 Volume:16 Page:567-575
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Llovet Patricia,Illana Francisco J.,Martín-Morales Lorena,de la Hoya Miguel,Garre Pilar,Ibañez-Royo M. Dolores,Pérez-Segura Pedro,Caldés Trinidad,García-Barberán Vanesa

Funder

Instituto de Salud Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics (clinical),Oncology,Genetics

Link

http://link.springer.com/article/10.1007/s10689-017-9990-0/fulltext.html

Reference22 articles.

1. Kamihara J, Rana HQ, Garber JE (2014) Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. Hum Mutat 35:654–662. doi: 10.1002/humu.22559

2. Vousden KH, Prives C (2009) Blinded by the Light: the growing complexity of p53. Cell 137:413–431. doi: 10.1016/j.cell.2009.04.037

3. Mai PL, Best AF, Peters JA et al (2016) Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer 122:3673–3681. doi: 10.1002/cncr.30248

4. Sorrell AD, Espenschied CR, Culver JO, Weitzel JN (2013) Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome†¯: current status of clinical applications and future directions. Mol Diagn Ther 17:31–47. doi: 10.1007/s40291-013-0020-0

5. Lalloo F, Varley J, Ellis D et al (2003) Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 361:1101–1102. doi: 10.1016/S0140-6736(03)12856-5

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous merkel cell carcinoma and acute myeloid leukaemia: A diagnostic challenge;Journal of Hematopathology;2024-08-17

2. Immunohistochemical findings and clinicopathological features of breast cancers with pathogenic germline mutations in Non-BRCA genes;Human Pathology;2024-04

3. TP53 Pathogenic Variants in Early-Onset Breast Cancer Patients Fulfilling Hereditary Breast and Ovary Cancer and Li-Fraumeni-like Syndromes;Biomolecules;2022-04-27

4. Reviewing the occurrence of large genomic rearrangements in patients with inherited cancer predisposing syndromes: importance of a comprehensive molecular diagnosis;Expert Review of Molecular Diagnostics;2022-03-04

5. Novel PTCH1 and concurrent TP53 mutations in four patients with numerous non‐syndromic basal cell carcinomas: The paradigm of oncogenic synergy;Experimental Dermatology;2021-12-17